Artificial Intelligence

Targeting advisor frustration, Wallace Finance launches a unified AI platform for wealth managers, aiming to cut costs and democratize advanced investing.

Startup Crumb just won a major tech award for its pet safety platform. Its secret? An AI that scans your dog's nose print, creating an unforgeable ID.

A new white-label infrastructure from PsyMetrics allows independent HR advisors to rebrand assessment tech, aiming to end "client leakage" to large vendors.

As event spending soars, the gap between CMOs and CFOs widens. A new summit aims to forge a tech-driven truce with a new financial model.

RBC's mid-year outlook reveals a resilient bull market powered by stellar earnings, but warns of historical volatility as yields and election risks loom.

A new strategic partnership aims to overcome drug resistance in GI cancers by combining Lonza's advanced ADC platform with Antharis's targeted antibody expertise.

At Automate 2026, Taiwan isn't just selling robots. It's offering a strategic partnership to rebuild U.S. manufacturing with its advanced AI and automation.

With Intel's new Panther Lake chips, ARBOR Technology is moving AI model training from the cloud to the device, promising a new era of truly adaptive automation.

BetterAge's new executive team signals a potent strategy: combining deep industry partnerships with advanced AI to scale in the competitive elder care market.

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

As biopharma navigates a maze of privacy laws and AI, a new platform aims to centralize patient consent, turning a compliance nightmare into a bridge for trust.

As AI drug discovery faces a crucial test, Terray Therapeutics hires a proven dealmaker. Can Lisa Decker translate digital promise into clinical reality?

The online therapy market is booming, attracting institutional capital. We dissect the growth drivers, regulatory risks, and evolving business models.

As AI promises to revolutionize medicine, enterprises face complex challenges. A new ISG study aims to chart the critical partner ecosystem.

As AI-powered cyberattacks escalate, Lumos has launched its 'Identity Agent Force,' an autonomous team of AI agents designed to defend the enterprise.

Immuta's expanded Databricks partnership introduces a new security paradigm for autonomous AI, promising to turn a critical risk into a commercial advantage.

Big Pharma is pouring over $1 billion into AI to design complex drugs, trading lab guesswork for algorithms. It's a high-stakes play to fix a broken R&D model.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

Chicago's Automate 2026 isn't just a tech show. It's a critical look at how AI and robotics are solving today's business crises and shaping future profits.

The ORBIE Awards are more than a trophy. They reveal a fundamental shift in tech leadership, where peer networks and strategic vision now drive innovation.